Replies to post #55188 on RespireRx Pharmaceuticals Inc (fka RSPI)

[LTListener]

Might be much to unveil..

Path to multiple clinical trials.. funding and grants..

[LTListener]

Biggest thing is to leverage their preclinical and past clinical success to get onto a path for clinical trials in pain, SCI, ADHD and epilepsy..

Then this can really grow from nickels and dimes levels to maybe $975…. 😂